#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Internal Medicine / 2019 - 1

Potential possibility of phosphocreatine usage in internal medicine

Česká verzia

Authors: Matej Vnučák 1;  Renáta Michalová Jr 1;  Karol Graňák 2;  Jakub Benko 1;  Marián Mokáň 1
Authors place of work: I. interná klinika JLF UK a UNM, Martin, Slovenská republika 1;  Chirurgická klinika a Transplantačné centrum JLF UK a UNM, Martin, Slovenská republika 2
Published in the journal: Vnitř Lék 2019; 65(1): 30-36
Category:

Summary

Adenosintriphosphate is basic unit of cellular energetics, although during situations of high energy demand, cell had developed metabolic inert molecules – phosphagens – including phosphocreatine. Nowadays there are not so many recent publications describing positive effect of phosphocreatine supplementation., its potential benefit in supplementation is mainly in cardiology – acute myocardial infarction, acute or chronic heart failure. Another field of medicine with potential use of phosphocreatine is nephrology – in dialysis patients, or in psotemnopausal women in prevention of osteoporosis. In following article, we present review of studies describing positive effect of using phosphocreatine in specific group of patients in internal medicine.

Key words:

ATP – ischemia – phosphagens – phosphocreatine

Zdroje
  1. Solomons GS, Wyss M et al. Creatine and creatinekinase in health and disease. Springer: Dordrecht (NL) 2007. ISBN 978–1-4020–6485–2.
  2. Ellington WR. Evolution and physiological roles of phosphagen systems. Annu Rev Physiol 2001; 63: 289–325. Dostupné z DOI: <http://dx.doi.org/10.1146/annurev.physiol.63.1.289>.
  3. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80(3): 1107–1213. Dostupné z DOI: <http://dx.doi.org/10.1152/physrev.2000.80.3.1107>.
  4. Stead LM, Brosnan JT, Brosnan ME et al. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 2006; 83(1): 5–10. Dostupné z DOI: <http://dx.doi.org/10.1093/ajcn/83.1.5>.
  5. Harris RC, Lowe JA, Warnes K et al. The concentration of creatine in meat, off al and commercial dogfood. Res Vet Sci 1997; 62(1): 58–62.
  6. Wallimann T, Tokarska-Schlattner M, Neumann D et al. The phospho-creatine circuit: molecular and cellular physiology of creatinekinases, sensitivity to free radicals and enhancement by creatine supplementation. In: Saks VA (ed). Molecular Systems Bioenergetics : Energy for Life Wiley‐VCH Verlag 2007: 195–264. ISBN 9783527621095 (on-line). ISBN (print): 9783527317875. Dostupné z DOI: <http://dx.doi.org/10.1002/9783527621095.ch7>.
  7. Schlattner U, Tokarska-Schlattner M, Wallimann T. Mitochondrial creatinekinase in humanhealth and disease. Biochim Biophys Acta 2006; 1762(2): 164–180. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bbadis.2005.09.004>.
  8. Lenz H, Schmidt M, Welge V et al. The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo. J Invest Dermatol 2005; 124(2): 443–452. Dostupné z DOI: <http://dx.doi.org/10.1111/j.0022–202X.2004.23522.x>.
  9. Balestrino M, Sarocchi M, Adriano E et al. Potential of creatine of phospho creatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids 2016; 48(8): 1955–1967. Dostupné z DOI: <http://dx.doi.org/10.1007/s00726–016–2173–8>.
  10. Gualano B, Ferreira DC, Sapienza MT et al. Effect of short-term high-dose creatine supplementation on measured GFR in a young man with a single kidney. Am J Kidney Dis 2010; 55(3): 7–9. Dostupné z DOI: <http://dx.doi.org/10.1053/j.ajkd.2009.10.053>.
  11. [National Kidney Foundation]. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49(2 Suppl 2): S1-S180.
  12. Anderson JW, Blake JE, Turner J et al. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998; 68(6 Suppl): 1347–1353. Dostupné z DOI: <http://dx.doi.org/10.1093/ajcn/68.6.1347S>.
  13. Pagenkemper J. Planning a vegetarian renal diet. J Ren Nutr 1995; 5(4): 234–238. Dostupné z DOI: <https://doi.org/10.1016/1051–2276(95)90009–8>.
  14. Hung CJ, Huang PC, Li YH et al. Taiwanese vegetarians have higher insulin sensitivity than omnivores. Br J Nutr 2006; 95(1): 129–135.
  15. Trilok G, Draper HH Sources of protein-induced endogenous acid production and excretion by human adults. Calcif Tissue Int 1989; 44(5): 335–338.
  16. Chang CT, Wu CH, Yang CW et al. Creatine monohydrate treatment all eviates muscle cramps associated with haemodialysis. Nephrol Dial Transplant 2002; 17(11): 1978–1981.
  17. Zhang J, Zeng H, Wang N et al. Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schonlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels. Eur J Pediatr 2016; 175(1):49–55. Dostupné z DOI: <https://doi: 10.1007/s00431–015–2601-x>.
  18. Tokarska-Schlattner M, Dolder M, Gerber I et al. Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: particular sensitivity of the heart. Biochim Biophys Acta 2007; 1767(11): 1276–1284. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bbabio.2007.08.006>.
  19. Terjung RL, Clarkson P, Eichner ER et al. American College of Sports Medicine round table: the physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc 2000; 32(3): 706–717.
  20. McConell GK, Shinewell J, Stephens TJ et al. Creatine supplementation reduces muscle in adenosinemonophosphate during endurance exercise in humans. Med Sci Sports Exerc 2005; 37(12): 2054–2061.
  21. Derave W, Eijnde BO, Verbessem P et al. Combined creatine and protein supplementation in conjunction with resistance training promotes muscle GLUT-4 content and glucose tolerance in humans. J Appl Physiol 2003; 94(5): 1910–1916. Dostupné z DOI: <http://dx.doi.org/10.1152/japplphysiol.00977.2002>.
  22. Willoughby DS, Rosene J. Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 2001; 33(10): 1674–1681.
  23. Deldicque L, Louis M, Theisen D et al. Increased IGF mRNA in human skeletal muscle after creatine supplementation. Med Sci Sports Exerc 2005; 37(5): 731–736.
  24. Willoughby DS, Rosene JM. Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med Sci Sports Exerc 2003; 35(6): 923–929. Dostupné z DOI: <http://dx.doi.org/10.1249/01.MSS.0000069746.05241.F0>.
  25. Poortmans JR, Kumps A, Duez P et al. Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate. Med Sci Sports Exerc 2005; 37(10): 1717–1720.
  26. Louis M, Poortmans JR, Francaux M et al. No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise. Am J Physiol Endocrinol Metab 2003; 285(5): E1089-E1094. Dostupné z DOI: <http://dx.doi.org/10.1152/ajpendo.00195.2003>.
  27. Rae C, Digney AL, McEwan SR et al. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci 2003; 270(1529): 2147–2150. Dostupné z DOI: <http://dx.doi.org/10.1098/rspb.2003.2492>.
  28. McMorris T, Mielcarz G, Harris RC et al. Creatine supplementation and cognitive performance in elderly individuals. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2007; 14(5): 517–528. Dostupné z DOI: <http://dx.doi.org/10.1080/13825580600788100>.
  29. Chilibeck PD, Chrusch MJ, Chad KE et al. Creatinemonohydrate and resistance training increase bone mineral content and density in older men. J Nutr Health Aging 2005; 9(5): 352–353.
  30. Gerber I, Gerber H, Dora C et al. Creatine supplementation stimulates collagen type I and osteoprotegerin secretion of healthy and osteopenic primary human osteoblast-like cells in vitro. Bone 2008; 42(Suppl 1): S21–S22. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2007.12.021>.
  31. Johnston AP, Burke DG, MacNeil LG et al. Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance. J Strength Cond Res 2009; 23(1): 116–120.
  32. Saks VA, Dzhaliashvili IV, Konorev EA et al. Molecular celular aspects of the cardioprotective mechanism of phosphocreatine. Biokhimiia 1992; 57(12): 1763–1784.
  33. Zhang W, Zhang H, Xing Y. Protective effects of phosphocreatine administered post- treatment combined with ischemic post-conditioning on rathearts with myocardial ischemia/reperfusion injury. J Clin Med Res 2015; 7(4): 242–247. Dostupné z DOI: <http://dx.doi.org/10.14740/jocmr2087w>.
  34. Gaddi AV, Galuppo P, Yang J. Creatine phosphate administration in cell energy impairment conditions: A summary of past and present research. Heart Lung Circ 2017; 26(10): 1026–1035. Dostupné z DOI: <http://dx.doi.org/10.1016/j.hlc.2016.12.020>.
  35. Ruda M, Samarenko MB, Afonskaya NI et al. Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction. Am Heart J 1988; 116(2 Pt 1): 393–397.
  36. Perepech NB, Nedoshivin AO, Kutuzova AE. Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction. Klin Med 1993; 71(1): 19–22.
  37. Ke-Wu D, Xu-Bo S, Ying-Xin Z et al. The effect of exogenous creatine phosphate on myocardial injury after percutaneous coronary intervention. Angiology 2015; 66(2): 163–168. Dostupné z DOI: <http://dx.doi.org/10.1177/0003319713515996>.
  38. Skrivanek O, Kalvach P, Benetin J et al. Kreatinfosfát v léčbě akutních ischemických iktů. Prakticky Lekar 1995; 75(7–8): 347–351.
  39. Weiduschat N, Mao NX, Beal MF et al. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson’s disease. J Neuro imaging 2015; 25(1): 105–110. Dostupné z DOI: <http://dx.doi.org/10.1111/jon.12074>.
Štítky
Diabetology Endocrinology Internal medicine
Článek Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry
Článek Non-celiac gluten/wheat sensitivity: still more questions than answers
Článek Diagnostic pitfalls of celiac disease
Článek Direct oral anticoagulants in oncology in clinical praxis
Článek The combination of acromegaly and Klinefelter syndrome in one patient
Článok vyšiel v časopise

Internal Medicine

Číslo 1
2019 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#